Erratum: A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma (Journal of the American Academy of Dermatology (2015) 73 (99-105))

H. Sofen, K. G. Gross, Leonard Harry Goldberg

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)780
Number of pages1
JournalJournal of the American Academy of Dermatology
Volume74
Issue number4
DOIs
StatePublished - Apr 1 2016

ASJC Scopus subject areas

  • Dermatology

Cite this